I am starting to get concerned about the "evidence" for a 4th shot.
The initial study of the 4th shot in HCW in Israel wasn't great for effectiveness against breakthrough infection. It only was significant for over 60s,
Now if a new drug is trialled and the results don't reach statistical signicance that drug basically needs new larger trials or is forgotten.
Well the Israelis went with a new larger trial which did show effectiveness and on that basis the CDC has approved a 4th dose at least 4 months after the third dose,
However you will note that larger study was of 700000 Israelis 600000 of them over 60. Talk about selecting your study patients to get the result you wanted.
What concerns me is that this didn't worry the CDC Why is it so? Is it because Pfizer and Moderna are US businesses? I mean they approved the US adenovirus vector vaccine but not the UK based one even though side effects basically the same and the UK product was cheaper and studied in far greater numbers.